Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
REATA PHARMACEUTICALS INC | Director | Class A common stock | 0 | $172.03 | Sep 26, 2023 | Direct | |
REATA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | Sep 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RETA | REATA PHARMACEUTICALS INC | Sep 26, 2023 | 8 | $0 | 4 | Sep 26, 2023 | Director |
RETA | REATA PHARMACEUTICALS INC | Jul 28, 2023 | 7 | -$596K | 4 | Aug 1, 2023 | Director |
RETA | REATA PHARMACEUTICALS INC | Jun 7, 2023 | 4 | $242K | 4 | Jun 9, 2023 | Director |
RETA | REATA PHARMACEUTICALS INC | Mar 10, 2023 | 7 | -$283K | 4 | Mar 13, 2023 | Director |
RETA | REATA PHARMACEUTICALS INC | Jun 8, 2022 | 4 | $220K | 4 | Jun 9, 2022 | Director |
RETA | REATA PHARMACEUTICALS INC | Jan 3, 2022 | 2 | $6.44K | 4 | Jan 5, 2022 | Director |
RETA | REATA PHARMACEUTICALS INC | Jun 10, 2021 | 2 | $64.9K | 4 | Jun 14, 2021 | Director |